A human study to evaluate the efficacy of ethanolic extract of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim on blood glucose

A randomized, double-blind, placebo-controlled study to evaluate the efficacy of ethanolic extract of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim on blood glucose

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001280

Enrollment

Registered

2014-11-20

Start date

2014-05-22

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consumption of placebo or Eleutherococcus senticosus (Rupr. & Maxim.) Maxim extract for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age: = 20 years and = 65 2) Fasting blood glucose: = 100 mg/dl and = 125 mg/dl 3) HbA1c: < 7.0% 4) Subject who voluntarily agrees to participate and signs in informed consent form

Exclusion criteria

Exclusion criteria: 1) Administration of drugs, dietary supplements or oriental medicine that affects blood glucose metabolism within 4 weeks before the first visit 2) Participation in other human study within 4 weeks before the first visit 3) Administration of hypoglycemic agent within 3 months 4) Pregnant or lactating women 5) Alcohol abuse 6) Uncontrolled hypertension (> 180/90 mm Hg) 7) Hyperlipidemia 8) Subject with following diseases (renal dysfunction, hepatic dysfunction, malignant tumor, mental illness) 9) Subjects with hypersensitivity to test materials 10) Illiterate

Design outcomes

Primary

Measure	Time frame
Markers of blood glucose	—

Secondary

Measure	Time frame
Markers of lipid metabolism;Antioxidative markers, etc.	—

Countries

Korea, Republic of

Contacts

Public ContactHyun Lim

Kyung Hee University

Outcome results